KALV |
KalVista Pharmaceuticals, Inc. |
May 17, 2024 |
6 |
-$95.2K |
4 |
May 21, 2024 |
CHIEF SCIENTIFIC OFFICER |
KALV |
KalVista Pharmaceuticals, Inc. |
Feb 17, 2024 |
8 |
-$398K |
4 |
Feb 21, 2024 |
CHIEF SCIENTIFIC OFFICER |
KALV |
KalVista Pharmaceuticals, Inc. |
Feb 14, 2024 |
1 |
-$423K |
4 |
Feb 16, 2024 |
CHIEF SCIENTIFIC OFFICER |
KALV |
KalVista Pharmaceuticals, Inc. |
Feb 11, 2024 |
2 |
$0 |
4 |
Feb 13, 2024 |
CHIEF SCIENTIFIC OFFICER |
KALV |
KalVista Pharmaceuticals, Inc. |
Jan 11, 2024 |
1 |
-$296K |
4 |
Jan 12, 2024 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Jan 8, 2024 |
2 |
-$225K |
4 |
Jan 10, 2024 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Nov 17, 2023 |
5 |
-$40.8K |
4 |
Nov 21, 2023 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Aug 17, 2023 |
5 |
-$53.4K |
4 |
Aug 21, 2023 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Feb 17, 2023 |
1 |
$0 |
4/A |
May 22, 2023 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Jan 11, 2023 |
5 |
-$18.1K |
4 |
May 19, 2023 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Nov 17, 2022 |
3 |
-$2.88K |
4 |
Nov 21, 2022 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Aug 17, 2022 |
3 |
-$7.96K |
4 |
Aug 19, 2022 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
May 17, 2022 |
2 |
$0 |
4 |
May 19, 2022 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Jan 7, 2022 |
4 |
$435K |
4 |
Jan 11, 2022 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Nov 1, 2021 |
1 |
-$108K |
4 |
Nov 3, 2021 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Aug 2, 2021 |
1 |
-$123K |
4 |
Aug 4, 2021 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
Jun 1, 2021 |
4 |
-$908K |
4 |
Jun 3, 2021 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
May 26, 2021 |
1 |
$0 |
4 |
May 28, 2021 |
Chief Scientific Officer |
KALV |
KalVista Pharmaceuticals, Inc. |
May 3, 2021 |
1 |
-$149K |
4/A |
May 7, 2021 |
Chief Scientific Officer |